Raloxifene [orch, phsu]
CARDIOVASCULAR [bdsy]
Health [idcn]
Relationship [qlco]
Lipid [lipd]
glucose metabolism [moft]
haemostatic [ortf]
Inflammation [patf]
Factor [ftcn]
Cardiovascular function [ortf]
postmenopausal [tmco]
Women [popg]
CHD [topp]
One [qnco]
Most [qnco]
Common [qnco]
Serious [qlco]
chronic [tmco]
condition [dsyn]
postmenopausal [tmco]
Women [popg]
???lead [elii, hops]
To [qlco]
High Risk [qlco]
recurrent myocardial infarction [dsyn]
Death [orgf]
Currently [tmco]
Available [ftcn]
Randomized Clinical Trial [inpr, resa]
Result [ftcn]
Role [socb]
Conventional [qlco]
HRT [topp]
treatment [ftcn]
Prevention [topp]
CHD [topp]
Rapidly [qlco]
Evolving [ftcn]
Benefit [qnco]
Proven [qlco]
Categories [inpr]
Women [popg]
Reason [idcn]
Interest [menp]
Potential [qlco]
Clinical [qlco]
Selective Estrogen Receptor Modulators [horm, phsu]
Selective Estrogen Receptor Modulators [horm, phsu]
Class [inpr]
Compound [qlco]
ACT [topp]
Estrogen Receptor Agonists [moft]
Domain [ftcn]
Bone [bpoc]
Lipids [lipd]
ACT [topp]
Estrogen Receptor Antagonists [moft]
Others [fndg]
Breast [bpoc]
Uterus [bpoc]
Raloxifene Hydrochloride [orch, phsu]
Antiestrogen [phsu]
Currently [tmco]
Approved [qlco]
Only [qnco]
TREAT [ftcn]
Osteoporosis [dsyn]
postmenopausal [tmco]
Women [popg]
effects [qlco]
Lipids [lipd]
Biomarkers [clna]
CARDIOVASCULAR [bdsy]
Risk [qlco]
Great [qnco]
Interest [menp]
Benefit [qnco]
Cardiovascular system [bdsy]
Great [qnco]
majority [socb]
Data [idcn]
CARDIOVASCULAR [bdsy]
Effect [qlco]
Raloxifene [orch, phsu]
Concern [idcn]
effects [qlco]
Lipids [lipd]
Marker [clna]
Thrombosis [patf]
Inflammation [patf]
Purpose [ftcn]
Review [inpr]
To [qlco]
Best [qlco]
Available [ftcn]
Evidence [ftcn]
Concern [idcn]
Raloxifene [orch, phsu]
Cardiovascular disease [dsyn]
focusing [clna]
Known [qlco]
To [qlco]
risk factors [qnco]
Cardiovascular Diseases [dsyn]
Lipids [lipd]
Lipoproteins [aapp, bacs]
glucose metabolism [moft]
haemostatic [ortf]
Factor [ftcn]
Marker [clna]
Inflammation [patf]
Cardiovascular function [ortf]
